Defence Therapeutics: Making a Global Impact
Defence Therapeutics is a Canadian Biotech company developing next generation bio-pharmaceutical innovations for various immuno-oncology (IO) and infectious diseases (ID) indications.
Stocks to Invest in: Healthcare
Defence Therapeutics is a Canadian Biotech company developing next generation biopharmaceutical innovations for various immuno-oncology (IO) and infectious diseases (ID) indications.
The company is located in Quebec, and their leadership team brings extensive eperience in the capital markets, finance, biochemistry, pharmacology, biotech, immunology.
Their platform is known as ACCUM, which is suitable to enhance the delivery of proteins, RNA and DNA.
Accum is overcoming problematic cell recycling and rejection patterns, ACCUM™ is the first solution to enable ADCs to control intracellular delivery of chemotherapeutic drugs, resulting in superior pre-clinical anti-tumor activity.
For more information on Defence Therapeutics Inc. (CSE: DTC, OTC: DTCFF) please click the request investor info button.
Latest Articles
.png)
Hot Companies
You might also like
Yukon Metals: Could the AZ Project Unlock a Major Copper Discovery in Yukon?
Yukon Metals is advancing copper exploration at its flagship AZ Project in Yukon, where they recently announced the presence of a new porphyry-style hydrothermal system with copper, gold and molybdenum mineralization at the Viper Porphyry Prospect
Selkirk Copper: Can the Minto Mine Restart Drive Yukon’s Next Copper Production?
Selkirk Copper is advancing the redevelopment of Yukon’s Minto copper-gold-silver mine, backed by a positive Preliminary Economic Assessment outlining a 13-year mine life and a substantial exploration program.
